RA Capital Management reports acquisition of $32,430 in SpyGlass Pharma common shares
SGP•RA Capital Management reported purchasing 1,000 SpyGlass Pharma common shares at $32.43 each. The filing lists indirect holdings of 5,967,439 shares and a separate position of 2,054,678 shares.
1. Share purchase
RA Capital Management reported purchasing 1,000 SpyGlass Pharma common shares at $32.43 per share. The filing lists indirect holdings of 5,967,439 common shares and a separate 2,054,678-share position. Joint reporting owners Peter Kolchinsky and Rajeev M. Shah are both listed as directors and 10% owners.




